Matthew O'Brien
Stock Analyst at Piper Sandler
(0.21)
# 4,497
Out of 4,651 analysts
1277
Total ratings
42.2%
Success rate
-3.9%
Average return
Main Sectors:
Stocks Rated by Matthew O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintained: Hold | $85 | $91.27 | -6.87% | 62 | Aug 14, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $38 → $45 | $42.08 | +6.94% | 5 | Aug 14, 2026 | |
| TELA TELA Bio | Maintained: Hold | $1 | $0.6443 | +55.21% | 27 | Aug 11, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $9 → $10 | $4.41 | +126.76% | 10 | Aug 11, 2026 | |
| GMED Globus Medical | Maintained: Buy | $100 | $85.90 | +16.41% | 56 | Aug 7, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $33 | $22.72 | +45.25% | 35 | Aug 7, 2026 | |
| CVRX CVRx, Inc. | Downgraded: Hold | $12 → $4 | $3.08 | +29.87% | 24 | Aug 7, 2026 | |
| SI Shoulder Innovations | Reiterated: Buy | $19 → $25 | $20.73 | +20.60% | 5 | Aug 7, 2026 | |
| CARL Carlsmed | Reiterated: Buy | $18 | $14.32 | +25.70% | 6 | Aug 6, 2026 | |
| ATEC Alphatec Holdings | Reiterated: Buy | $14 | $9.79 | +43.00% | 38 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $25 | $24.80 | +0.81% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $100 | $88.58 | +12.89% | 40 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $25 | $21.65 | +15.47% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $18.93 | +32.07% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $97 → $127 | $125.26 | +1.39% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $95 | $89.75 | +5.85% | 67 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $420 → $390 | $339.21 | +14.97% | 54 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $45 | $50.41 | -10.73% | 42 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $17.57 | +13.83% | 12 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $44.30 | +12.87% | 42 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $28.02 | +7.07% | 7 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $143.34 | +46.50% | 38 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $65 | $51.83 | +25.41% | 61 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $20.15 | -20.60% | 2 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.6922 | +333.40% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $327.02 | +14.37% | 18 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $100.65 | - | 42 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $8.14 | n/a | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $26.18 | n/a | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $245 → $140 | $137.17 | n/a | 26 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $11 | $7.85 | n/a | 20 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $180 | $184.53 | n/a | 62 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4.5 → $2 | $3.03 | n/a | 26 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $3 | $0.6048 | n/a | 7 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $44 | $18.34 | n/a | 38 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $90 | $0.0001 | n/a | 15 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $0.941 | n/a | 7 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $3.30 | n/a | 24 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 | $26.73 | n/a | 16 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $79 | $90.76 | n/a | 25 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $24.20 | n/a | 14 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $3.40 | n/a | 6 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $435 | $76.17 | n/a | 30 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $0.28 | n/a | 10 | Jan 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $7 | $0.000001 | n/a | 8 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $73 | $82.22 | n/a | 38 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $258 → $345 | $181.31 | n/a | 35 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 → $633 | $394.51 | n/a | 27 | Sep 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $3 | $7.45 | n/a | 3 | Jan 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.27 | n/a | 9 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $96 | $5.75 | n/a | 8 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $69 | $11.59 | n/a | 9 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $70 | $224.46 | n/a | 8 | Aug 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.305 | n/a | 2 | Aug 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.12 | n/a | 2 | May 8, 2012 |
Medtronic
Aug 14, 2026
Maintained: Hold
Price Target: $85
Current: $91.27
Upside: -6.87%
HeartFlow
Aug 14, 2026
Reiterated: Buy
Price Target: $38 → $45
Current: $42.08
Upside: +6.94%
TELA Bio
Aug 11, 2026
Maintained: Hold
Price Target: $1
Current: $0.6443
Upside: +55.21%
Orchestra BioMed Holdings
Aug 11, 2026
Reiterated: Buy
Price Target: $9 → $10
Current: $4.41
Upside: +126.76%
Globus Medical
Aug 7, 2026
Maintained: Buy
Price Target: $100
Current: $85.90
Upside: +16.41%
Tandem Diabetes Care
Aug 7, 2026
Reiterated: Buy
Price Target: $33
Current: $22.72
Upside: +45.25%
CVRx, Inc.
Aug 7, 2026
Downgraded: Hold
Price Target: $12 → $4
Current: $3.08
Upside: +29.87%
Shoulder Innovations
Aug 7, 2026
Reiterated: Buy
Price Target: $19 → $25
Current: $20.73
Upside: +20.60%
Carlsmed
Aug 6, 2026
Reiterated: Buy
Price Target: $18
Current: $14.32
Upside: +25.70%
Alphatec Holdings
Aug 5, 2026
Reiterated: Buy
Price Target: $14
Current: $9.79
Upside: +43.00%
Aug 5, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $24.80
Upside: +0.81%
Aug 5, 2026
Reiterated: Buy
Price Target: $120 → $100
Current: $88.58
Upside: +12.89%
Aug 5, 2026
Maintained: Buy
Price Target: $35 → $25
Current: $21.65
Upside: +15.47%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $18.93
Upside: +32.07%
Aug 3, 2026
Downgraded: Hold
Price Target: $97 → $127
Current: $125.26
Upside: +1.39%
Jul 31, 2026
Reiterated: Buy
Price Target: $88 → $95
Current: $89.75
Upside: +5.85%
Jul 31, 2026
Maintained: Buy
Price Target: $420 → $390
Current: $339.21
Upside: +14.97%
Jul 30, 2026
Reiterated: Hold
Price Target: $39 → $45
Current: $50.41
Upside: -10.73%
Jul 30, 2026
Reiterated: Buy
Price Target: $20
Current: $17.57
Upside: +13.83%
Jul 24, 2026
Maintained: Buy
Price Target: $50
Current: $44.30
Upside: +12.87%
Jul 15, 2026
Maintained: Buy
Price Target: $30
Current: $28.02
Upside: +7.07%
Jun 15, 2026
Maintained: Buy
Price Target: $210
Current: $143.34
Upside: +46.50%
Jun 12, 2026
Maintained: Buy
Price Target: $90 → $65
Current: $51.83
Upside: +25.41%
Jun 4, 2026
Reiterated: Hold
Price Target: $16
Current: $20.15
Upside: -20.60%
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.6922
Upside: +333.40%
Jan 15, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $327.02
Upside: +14.37%
Oct 13, 2025
Maintained: Hold
Price Target: n/a
Current: $100.65
Upside: -
May 9, 2025
Maintained: Hold
Price Target: $3.5
Current: $8.14
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $16
Current: $26.18
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $245 → $140
Current: $137.17
Upside: n/a
Feb 14, 2025
Maintained: Hold
Price Target: $12 → $11
Current: $7.85
Upside: n/a
Jan 27, 2025
Maintained: Buy
Price Target: $140 → $180
Current: $184.53
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $4.5 → $2
Current: $3.03
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5 → $3
Current: $0.6048
Upside: n/a
Jun 26, 2023
Maintained: Hold
Price Target: $55 → $44
Current: $18.34
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $10 → $90
Current: $0.0001
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $9 → $11
Current: $0.941
Upside: n/a
Nov 9, 2021
Maintained: Buy
Price Target: $12 → $10
Current: $3.30
Upside: n/a
Sep 2, 2021
Maintained: Hold
Price Target: $82
Current: $26.73
Upside: n/a
Jul 30, 2021
Maintained: Buy
Price Target: $62 → $79
Current: $90.76
Upside: n/a
Jul 6, 2021
Maintained: Buy
Price Target: $70
Current: $24.20
Upside: n/a
Mar 23, 2021
Maintained: Hold
Price Target: $3.5
Current: $3.40
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $370 → $435
Current: $76.17
Upside: n/a
Jan 27, 2021
Maintained: Hold
Price Target: $7
Current: $0.28
Upside: n/a
Jan 12, 2021
Maintained: Buy
Price Target: $4 → $7
Current: $0.000001
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $70 → $73
Current: $82.22
Upside: n/a
Jul 23, 2020
Maintained: Buy
Price Target: $258 → $345
Current: $181.31
Upside: n/a
Sep 25, 2019
Maintained: Buy
Price Target: $600 → $633
Current: $394.51
Upside: n/a
Jan 7, 2018
Reiterated: Buy
Price Target: $10 → $3
Current: $7.45
Upside: n/a
Dec 13, 2017
Reiterated: Buy
Price Target: $18
Current: $4.27
Upside: n/a
Nov 7, 2017
Reiterated: Hold
Price Target: $90 → $96
Current: $5.75
Upside: n/a
Aug 9, 2017
Reiterated: Buy
Price Target: $73 → $69
Current: $11.59
Upside: n/a
Aug 2, 2017
Reiterated: Hold
Price Target: $65 → $70
Current: $224.46
Upside: n/a
Aug 14, 2014
Maintained: Buy
Price Target: n/a
Current: $0.305
Upside: n/a
May 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $10.12
Upside: n/a